New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 23, 2014
09:09 EDTFLXN, MNK, INSYBMO Capital specialty pharma analyst holds analyst/industry conference call
Specialty Pharmaceuticals Analyst Maris, along with President & CEO Nathaniel Katz, MD of Analgesic Solutions, discuss whether the FDA is looking for alternatives to complement the opioid pain relief medications on the market, including Mallinckrodtís Xartemis and MNK-155, Flexionís FX005 and Insysís Subsys on an Analyst/Industry conference call to be held on May 23 at 10 am.
News For MNK;FLXN;INSY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 29, 2015
16:46 EDTFLXNFlexion awarded $2M from DoD to conduct clinical trial of FX006
Subscribe for More Information
09:22 EDTFLXNFlexion files to sell $200M in common stock, preferred stock and warrants
Subscribe for More Information
April 28, 2015
10:05 EDTMNKOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:56 EDTMNKMallinckrodt reinstated with a Neutral at Goldman
Subscribe for More Information
April 27, 2015
06:19 EDTMNKPharmceutical companies buy drugs and raises prices, WSJ reports
Subscribe for More Information
April 24, 2015
15:09 EDTINSYInsys falls after SIRF links drug to 'growing number' of deaths
Subscribe for More Information
April 23, 2015
07:17 EDTINSYInsys Therapeutics commences dosing in Phase 1/2 study of CBD oral solution
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use